Global Therapeutics Manufacturer Selects Sparta System's TrackWise
HOLMDEL, NJ – April 7, 2009 –
Sparta Systems, Inc., the maker of TrackWise software, and the market leader in enterprise quality and compliance management, today announced that Chiesi Farmaceutici SPA, a pharmaceutical company dedicated to the research, development and commercialization of ethical therapeutic products, has selected its TrackWise Enterprise Quality Management System (EQMS) to reduce the cost of compliance and streamline organizational quality practices. Chiesi will leverage the TrackWise software specifically to manage quality processes including audits, non-conformance, corrective and preventative actions and workflow verification.
Stringent regulations guide every aspect of the development and production processes for pharmaceutical manufacturers, requiring companies to implement rigorous procedures for documentation and auditing. With the global economic downturn already limiting organizational resources, companies are recognizing the need to streamline processes and reduce the cost of compliance while maintaining high quality standards.
Like most life sciences companies, Chiesi previously relied on a paper-based model for tracking all corporate quality assurance (QA) processes. In order to more efficiently manage these crucial procedures, Chiesi sought an automated system that would reduce the time spent validating processes and identifying irregularities. By selecting Sparta Systems’ TrackWise software to manage audit workflow, Chiesi now expects to reduce cycle times and normalize data between departments, improving visibility by making reporting simpler and more accurate.
“Given Sparta Systems’ fundamental knowledge of the life sciences industry, quality practices and reporting requirements, Chiesi understood it had a partner that would leverage industry best practices to boost our compliance initiatives across the organization,” said Dr. Francesca Bacchini, corporate QA research and development head of Chiesi Farmaceutici Group. “In choosing the TrackWise Quality Management System to streamline audit processes, we expect to see a quick return on our investment, expanding the solution across our entire quality assurance unit.”
“TrackWise will enable Chiesi to improve quality and identify operational risks by facilitating the full lifecycle management of audits and help ensure that their findings are resolved in a timely and effective manner,” said Yaniv Vardi, general manager, Sparta Systems Europe. “Global organizations realize that in using TrackWise they can more efficiently manage quality across the global supply chain, reducing the cost of compliance and paving the way for future growth.”
About Chiesi Farmaceutici SPA
Chiesi Farmaceutici is a European pharmaceutical group with its headquarters in Parma, Italy. The Group's turnover reached 749 million Euro in 2008. Chiesi has marketing and sales organizations in all major European markets and distributes its products in over 50 countries worldwide through its affiliates and partners. The Group employs 3,243 people of whom approximately 300 are involved in research; besides the already existing R&D facilities in Italy, France, and the United States, a new research laboratory was established in Chippenham (UK) during 2008.
More information about the Chiesi Group, can be found at
www.chiesigroup.com
.
About Sparta Systems
Sparta Systems, Inc. is the industry leader for global quality and compliance management systems. Its TrackWise product is a Web-based software application used by quality, manufacturing, and regulatory affairs professionals to manage quality and compliance issues across the enterprise. The company has more than 14 years of experience and an extensive customer base in the life sciences and other highly regulated industries. Sparta Systems offers its customers a complete solution for global quality management needs, including the onsite support required throughout the project lifecycle. More information about Sparta Systems can be found at
www.spartasystems.com
.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
